Editors-in-Chief

  • Douglas R Galasko, University of California, San Diego
  • Todd E Golde, University of Florida
  • Philip Scheltens, VU University Medical Center

Society Affiliations

logo

Affiliated to Alzheimer's Disease International (ADI), London, United Kingdom

Alzheimer's Disease International is the international federation of national Alzheimer organisations and global voice for dementia, leading and unifying the dementia community to provide global solutions to a global epidemic.

Articles

There has been an error retrieving the data. Please try again.
  • Monoaminergic footprints of DLB and AD

    Alterations in monoaminergic neurotransmitters contribute differently to the neurochemical pathophysiology of depression and psychosis in dementia with Lewy bodies (DLB) compared to Alzheimer’s disease (AD).

    Alzheimer's Research & Therapy 2015, 7:7
  • Neuropsychiatric symptoms in Alzheimer’s dementia

    Lyketsos and colleagues review the current literature on the phenomenology and diagnosis, neurobiology, and treatment approaches for several key behavioral phenotypes in Alzheimer’s disease.

    Alzheimer's Research & Therapy 2015, 7:12
  • What can we learn from animal models?

    As part of the cerebral multi-morbidity series, Baker and Götz review the contribution that transgenic animal models have made to a better mechanistic understanding of the causes and consequences of co- or multi-morbidity.

    Alzheimer's Research & Therapy 2015, 7:11
  • CVRi elevation in the very-old

    Elevated cerebrovascular resistance (CVRi) in the very-old is associated with greater cerebrovascular disease burden and poorer cognitive function within regions associated with Alzheimer’s disease, demonstrating the potential of CVRi as a potential vascular biomarker.

    Alzheimer's Research & Therapy 2015, 7:3

Featured review

Review

Active immunotherapy options for Alzheimer’s disease

Bengt Winblad, Ana Graf, Marie-Emmanuelle Riviere, Niels Andreasen and J Michael Ryan

Alzheimer's Research & Therapy 2014, 6:7 (30 January 2014)

RSS

Comments

View more comments

Cerebral multimorbidity
Body-Dementia
Traumatic brain injury
Immuno Therapy
2014_01_AlzR&T_Tau_special_series
Alzheimer's Research & Therapy on Twitter
2014_01_alzheimer_research_&_therapy_peripheral_biomarkers
Alzres Manuscript

Aims & scope

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports. Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.

Article collections

View all article collections

Multimedia

The evolving field of traumatic brain injury

What do we currently know about chronic traumatic encephalopathy (CTE) and what are the most important questions in the field? Listen to a free podcast discussing this and more, as part of our special series on Traumatic Brain Injury.

Searching for biomarkers

As part of our special series on Peripheral Biomarkers, listen to a free podcast by Douglas Galasko about the advances and current issues in the search to identify blood biomarkers for Alzheimer's disease.

Submit a manuscript Sign up for article alerts Contact us

Email updates

Receive periodic news and updates relating to this journal straight to your inbox.

Indexed by

  • CAS
  • DOAJ
  • Embase
  • Journal Citation Reports/Science Edition
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • Scopus

View all

ISSN: 1758-9193